Drug Insight: Statin use in the elderly

Nature Clinical Practice Cardiovascular Medicine

Volumn 3, Issue 6, 2006, Pages 318-328

  Raffel, Christopher O ^a   White, Harvey D ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

Acute coronary syndrome; Elderly; Myocardial infarction; Statin

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; CREATINE KINASE; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; PLACEBO; PRAVASTATIN; SIMVASTATIN; TIROFIBAN;

ACUTE CORONARY SYNDROME; AGED; CANCER; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DRUG USE; EVIDENCE BASED MEDICINE; GERIATRIC CARE; GROUPS BY AGE; HEART INFARCTION; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; LIVER DYSFUNCTION; MORTALITY; MYALGIA; MYOPATHY; MYOSITIS; PATIENT COMPLIANCE; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; RHABDOMYOLYSIS; RISK REDUCTION; ST SEGMENT ELEVATION;

AGED; AGED, 80 AND OVER; CHOLESTEROL, LDL; CORONARY DISEASE; COST-BENEFIT ANALYSIS; DRUG UTILIZATION; HEALTH SERVICES FOR THE AGED; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; META-ANALYSIS; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT COMPLIANCE; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; RISK ASSESSMENT;

EID: 33744533641     PISSN: 17434297     EISSN: 17434300     Source Type: Journal    
DOI: 10.1038/ncpcardio0558     Document Type: Review

References (42)

1. Schwartz JB et al. (2005) Cardiovascular disease in the elderly. In Heart Disease: A Textbook of Cardiovascular Medicine, edn 7, 1925-1949 (Eds Braunwald E et al.) Philadelphia: WB Saunders
2. Mehta RH et al. (2001) Acute myocardial infarction in the elderly: differences by age. J Am Coll Cardiol 38: 736-741
3. Rich MW et al. (2003) Executive summary: Second Pivotal Research in Cardiovascular syndromes in the Elderly (PRICE-2) symposium. Acute coronary syndromes in the elderly: Mechanisms and management. Am J Geriatr Cardiol 12: 307-327
4. Rathore SS et al. (2003) Effects of age on the quality of care provided to older patients with acute myocardial infarction. Am J Med 114: 307-315
5. Alexander KP et al. (2005) Evolution in cardiovascular care for elderly patients with non-ST-segment elevation acute coronary syndromes: Results from the CRUSADE National Quality Improvement Initiative. J Am Coll Cardiol 46: 1479-1487
6. Krumholz HM et al. (1996) Aspirin for secondary prevention after acute myocardial infarction in the elderly: Prescribed use and outcomes. Ann Intern Med 124: 292-298
7. Ko DT et al. (2004) Lipid-lowering therapy with statins in high-risk elderly patients: The treatment-risk paradox. JAMA 291: 1864-1870
8. Fonarow GC et al. (2001) In-hospital initiation of lipid-lowering therapy for patients with coronary heart disease: The time is now. Circulation 103: 2768-2770
9. Gurwitz JH et al. (1992) The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA 268: 1417-1422
10. Alter DA et al. (2004) Age, risk-benefit trade-offs, and the projected effects of evidence-based therapies. Am J Med 116: 540-545
11. Hirth VA (2005) Aronow's "Should the NCEP III guidelines be changed in elderly and younger persons at high risk for cardiovascular events?" Hyperlipidemia in seniors: Too much, too little, too late? J Gerontol A Biol Sci Med Sci 60: 595-597
12. The Scandinavian Simvastatin Survival Study Group (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 344: 1383-1389
13. Sacks FM et al. (1996) The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 335: 1001-1009
14. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group (1998) Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 339: 1349-1357
15. Miettinen TA et al. (1997) Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: Findings from the Scandinavian Simvastatin Survival Study (4S). Circulation 96: 4211-4218
16. Lewis SJ et al. (1998) Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range: Results of the Cholesterol and Recurrent Events (CARE) trial. Ann Intern Med 129: 681-689
17. Hunt D et al. (2001) Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: Results from the LIPID trial. Ann Intern Med 134: 931-940
18. Baigent C et al. (2005) Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366: 1267-1278
19. Heart Protection Study Collaborative Group (2002) MRC/BHF Heart Protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial. Lancet 360: 7-22
20. Shepherd J et al. (2002) Pravastatin in elderly individuals at risk of vascular disease (PROSPER): A randomised controlled trial. Lancet 360: 1623-1630
21. Stenestrand U et al. (2001) Early statin treatment following acute myocardial infarction and 1-year survival. JAMA 285: 430-436
22. Aronow HD et al. (2003) In-hospital initiation of lipid-lowering therapy after coronary intervention as a predictor of long-term utilization: A propensity analysis. Arch Intern Med 163: 2576-2582
23. Newby LK et al. (2002) Early statin initiation and outcomes in patients with acute coronary syndromes. JAMA 287: 3087-3095
24. Schwartz GG et al. (2001) Effects of atorvastatin on early recurrent ischemic eveAts in acute coronary syndromes: The MIRACL study: a randomized controlled trial. JAMA 285: 1711-1718
25. Cannon CP et al. (2004) Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 350: 1495-1504
26. de Lemos JA et al. (2004) Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: Phase Z of the A to Z trial. JAMA 292: 1307-1316
27. National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (2002) Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106: 3143-3421
28. LaRosa JC et al (2005) Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 352: 1425-1435
29. Ray KK et al (2005) Validating the new NCEP III LDL target of <70mg/dl among elderly patients: An analysis from PROVE IT-TIMI 22. J Am Coll Cardiol 45 (Suppl A): S412A
30. Pasternak RC et al. (2002) ACC/AHA/NHLBI clinical advisory on the use and safety of statins. Circulation 106: 1024-1028
31. Rosenson RS (2004) Current overview of statin-induced myopathy. Am J Med 116: 408-416
32. Staffa JA et al. (2002) Cerivastatin and reports of fatal rhabdomyolysis. N Engl J Med 346: 539-540
33. Nissen SE (2004) High-dose statins in acute coronary syndromes: Not just lipid levels. JAMA 292: 1365-1367
34. Waters DD (2005) Safety of high-dose atorvastatin therapy. Am J Cardiol 96: 69F-75F
35. Bjerre LM and LeLoirer J (2001) Do statins cause cancer? A meta-analysis of large randomized clinical trials. Am J Med 110: 716-723
36. Strandberg TE et al. (2004) Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S). Lancet 364: 771-777
37. The LIPID Study Group (2002) Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: The LIPID trial follow-up. Lancet 359: 1379-1387
38. Mungall MM et al. (2003) Statin therapy in the elderly: Does it make good clinical and economic sense? Drugs Aging 20: 263-275
39. Tonkin AM et al. (2004) Cost-effectiveness of cholesterol-lowering therapy with pravastatin in patients with previous acute coronary syndromes aged 65-74 years compared with younger patients: Results from the LIPID study. Am Heart J, in press
40. Heart Protection Study Collaborative Group (2005) Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20 536 individuals. Lancet 365: 1779-1785
41. Jackevicius CA et al. (2002) Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 288: 462-467
42. Benner JS et al. (2002) Long-term persistence in use of statin therapy in elderly patients. JAMA 288: 455-461